There’s lots of obstacles to ensure patients can access clinically appropriate therapy, and even once they do start treatment, questions arise as to whether they’ll stay on the treatment, and even how effective it is. Solving abandonment and discontinuation in specialty drugs can be nonviable, unless you have the in-depth data to identify the cause, […]
Discontinued Medications: Causes in Specialty Drugs Read More »
ClaritasRX is proud to be a sponsor of this year’s PMSA Annual Conference, which will be held May 21–24, 2023, in San Diego.
7 Sessions We Are Looking Forward to at the 2023 PMSA Conference Read More »
Specialty drug market growth calls for greater attention to data resources. Here’s why.
Maintaining Foothold in Specialty Drug Market: Focus on Data Read More »
A successful product launch requires all hands on deck. Here’s how to foster communication with the right tools.
Coordinating Your Teams for a Successful Product Launch Read More »
What metrics help government payers understand value and cost controls for rare disease therapies?
Cost Control Measures for Rare Disease Therapies: A Guide Read More »
The Asembia 2023 Specialty Pharmacy Summit is the best place to meet industry decision-makers. See which sessions you want to attend at this conference.
Asembia 2023 Conference Preview Read More »
Comparing drug efficacy is essential — and backing it up with quantifiable data is a must.
Want to Compare Drugs’ Effectiveness? Track The Right Data Read More »
To help patients adhere to treatment protocols, collect patient-level data.
How Patient-Level Data Protects Against Medication Nonadherence Read More »
Why do patients fail to adhere to treatment protocols? We explore the bevy of reasons for patient nonadherence and what can be done about it.
What Drives Patient Nonadherence? Read More »
CMS’s value-based programs often look for lack: fewer infections, lower readmissions, etc. Here’s how to demonstrate non-events.
Tracking What’s Not There: How to Demonstrate Value to Public Payers Read More »